# Candesartan in Peripheral Neuropathy

> **NCT03688633** · PHASE2 · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 9 (actual)

## Conditions studied

- Peripheral Neuropathy

## Interventions

- **DRUG:** Candesartan
- **OTHER:** Usual care

## Key facts

- **NCT ID:** NCT03688633
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-01
- **Primary completion:** 2021-05-27
- **Final completion:** 2021-05-27
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Patient Recruitment Failure
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688633, "Candesartan in Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03688633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*